Strategic Acquisition Sinclair Research operates as a long-standing CRO with deep expertise in miniature swine and GLP/SEND capabilities, recently integrated into Altasciences. This positions the combined entity to cross-sell enhanced preclinical services and leverage Altasciences’ broader early-phase platform to win larger, integrated programs.

Expanded Capabilities The alignment with Altasciences expands from specialized nonclinical toxicology and animal health research into full preclinical and early clinical services, enabling a one-stop solution for sponsors seeking faster timelines and end-to-end development, which can be pitched to clients aiming to streamline vendor management.

Strategic Partnerships Recent and ongoing partnerships with Evidence Matters, Certara, and VoxCell BioInnovation enhance data science, model-informed drug development, and advanced 3D tissue testing, offering sales angles around predictive analytics, regulatory readiness, and more human-relevant safety assessments.

Sustainability & ESG EcoVadis ESG collaborations highlight a commitment to sustainable operations, presenting an opportunity to target sponsors with strong ESG criteria or regulatory incentives by emphasizing responsible research practices and reduced environmental footprint in proposals.

Award Momentum Recognition such as the 2025 CDMO Leadership Award in Small Molecule Dosage Form enhances credibility and can be leveraged in outreach to differentiate the firm, particularly when pursuing small-molecule programs and competitive bids that reward proven leadership.